Clinical Trials Sponsored by Windlas Biotech Private Limited
Total 1 results
-
Mateon TherapeuticsWindlas Biotech Private LimitedCompleted
Sponsors and Collaborators
- Italian Academy of Rhinology
- Spital Linth
- Hospital of Southern Jutland
- Kevin W Hatton, MD, PhD
- Iran Ministry of Health, Treatment, and Medical Education
- Azienda Sanitaria Locale N.1 dell'Umbria
- INESC TEC - Institute for Systems and Computer Engineering, Technology and Science (Porto, Portugal)
- Emergency Medical Service Ostrava, Ostrava, Czech Republic
- Daily Centre for Psychiatry and Speech Disorders Poland
- Institute of Child Health, London, England
- University of Crete Medical School - University Hospital of Heraklion
- Metiv Israel Psychotrauma Center
- Child Medical Center, 3 Rue de la Prugne, 63540 Romagnat, France
- Amy Farabaugh, PhD
- Skin Laser & Surgery Specialists
- Meng Li
- Permanente Dental Associates Group, Oregon
- EULAR Lupus Nephritis Trial Network Study Group
- North Tees and Hartlepool NHS Foundation Trust
- Anthony Johnson
- View Full List
Medical Conditions
- Sodium Selenite
- Indirect Incentive
- Tendon CSA
- Primary Lymphoma of the Central Nervous System
- Post-micturition Incontinence
- Neuralgia, Postherpetic
- Leiomyomas
- Relapsed/Refractory Large B-cell Lymphoma
- Peptic Ulcer With Haemorrhage
- Exercise Intolerance, Riboflavin-Responsive
- Mastoid Cavity
- Non-small Cell Lung Cancer Stage ⅢA
- Peripheral T-cell Lymphomas
- Crystal Meth Addiction
- Metformin Concentration
- Laxative Compatibility
- Haematologic Disease
- Thyroid Eye Disease
- Working Memory Training
- Management of Lung Cancer Patients
- View Full List
Drug Interventions
- Tranexamic acid
- Tenofovir
- Modified Bolus 5-FU/LV with Irinotecan
- Anastrozole
- Amisulpride Oral Tablet
- 30 mg CVL-231 as slow-release MR formulation
- 6-Mercaptopurine
- Follitropin beta liquid formulation
- Sodium Nitroprusside
- PCO371
- Cetuximab
- Sipuleucel-T
- Percutaneous sirolimus
- Ketamine 0.3 mg/kg at anesthesia induction
- Granulocyte colony-stimulating factor
- Trastuzumab in combination with SubQ GM-CSF
- Visanne (Dienogest, BAY86-5258)
- Nicoderm C-Q Transdermal Product
- Vinorelbine tartrate
- 5.0g SRT501
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Austria
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Brazil
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Ghana
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Mali
- Contract Research Organizations in Oman
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Zimbabwe
- CRO list by country